University of Limerick Institutional Repository

Exploration of GP perspectives on deprescribing antidepressants: a qualitative study

DSpace Repository

Show simple item record

dc.contributor.author Kelly, Dervla
dc.contributor.author Graffi, Justin
dc.contributor.author Noonan, Maria
dc.contributor.author Green, Philip
dc.contributor.author McFarland, John
dc.contributor.author Hayes, Peter
dc.contributor.author Glynn, Liam G.
dc.date.accessioned 2021-04-15T08:09:11Z
dc.date.available 2021-04-15T08:09:11Z
dc.date.issued 2021
dc.identifier.uri http://hdl.handle.net/10344/10000
dc.description peer-reviewed en_US
dc.description.abstract Objective Our aim was to explore general practitioners’ (GPs) perceptions and experiences of discontinuing antidepressants. Study design A qualitative study using semi structured interviews was undertaken between July 2019 and March 2020. The interviews were transcribed and analysed using a thematic analysis framework. Setting GPs affiliated with a university education and research network for general practice in Ireland. Participants A purposive sample of GPs (n=10). Results Five themes emerged: shared decision-making; personalised therapy; medication-tapering toolkit; health service factors and concerns around tapering. GPs described being less likely to engage in deprescribing for patients with long-term and/or recurrent depression, older patients and those with comorbidities due to fear of relapse. Access to evidence-based psychological therapies, guidelines, information on rates of relapse, patient leaflets on discontinuing antidepressants and reminder prompts on GP-prescribing software were suggested to optimise appropriate antidepressant discontinuation. There was some suggestion that patients may use antidepressants for longer when talk therapy is not available or taken up. Conclusions GPs are largely confident in their role of managing mild-to-moderate depression and deprescribing antidepressants. This study provides an insight into factors that influence GPs’ decisions to deprescribe antidepressants. More information on rates of relapse after discontinuation would be helpful to inform decision-making en_US
dc.language.iso eng en_US
dc.publisher BMC en_US
dc.relation.ispartofseries BMJ Open;11, e046054
dc.subject psychological en_US
dc.subject depression en_US
dc.subject antidepressants en_US
dc.title Exploration of GP perspectives on deprescribing antidepressants: a qualitative study en_US
dc.type info:eu-repo/semantics/article en_US
dc.type.supercollection all_ul_research en_US
dc.type.supercollection ul_published_reviewed en_US
dc.identifier.doi 10.1136/bmjopen-2020-046054
dc.rights.accessrights info:eu-repo/semantics/openAccess en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search ULIR


Browse

My Account

Statistics